688166 博瑞医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额151,220194,765311,259176,075155,432
投资活动产生之现金流量净额(291,746)(439,854)(871,576)(889,838)(541,923)
筹资活动产生之现金流量净额115,69361,6111,364,686703,722185,732
汇率变动对现金及现金等价物的影响1,9142,78314,1513,722(13,032)
现金及现金等价物净增加/(减少)(22,918)(180,694)818,520(6,319)(213,791)
期初现金及现金等价物余额971,0411,151,735333,215339,534553,324
期末现金及现金等价物余额948,123971,0411,151,735333,215339,534